1 |
(2r)-2-propyloctanoic acid |
- |
- |
- |
- |
002 1件: 2 💬 |
2 |
(6r)-4, 5, 6, 7 - tetrahydro-n6-propyl-2,6-benzothiazolidiamine dihydrochloride monohydrate |
- |
- |
- |
- |
002 1件: 2 💬 |
3 |
(r)-(-)-2-propyloctaroic acid |
- |
- |
- |
- |
002 1件: 2 💬 |
4 |
1.0 miu il-2 per day |
Human interleukin-2 |
- |
- |
- |
002 1件: 2 💬 |
5 |
2.0 miu il-2 per day |
Human interleukin-2 |
- |
- |
- |
002 1件: 2 💬 |
6 |
250 mg ck-2017357 |
- |
- |
- |
- |
002 2件: 2 , 11 💬 |
7 |
4 cholesten-3-one, oxime |
- |
- |
- |
- |
002 1件: 2 💬 |
8 |
4-cholesten-3-one, oxime |
- |
- |
- |
- |
002 2件: 2 , 3 💬 |
9 |
40 mg ga |
- |
- |
- |
- |
002 2件: 2 , 13 💬 |
10 |
40 mg glatiramer acetate |
Acetate |
1件: D04318 D04318 💬 |
HLA-A 20件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬 |
Allograft rejection 32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis |
002 2件: 2 , 13 💬 |
11 |
5% glucose water solution |
Dextrose, unspecified form |
1件: D00001 D00001 💬 |
- |
- |
002 1件: 2 💬 |
12 |
500 mg ck-2017357 |
- |
- |
- |
- |
002 2件: 2 , 11 💬 |
13 |
6-ethynyl-1-(pentan-3-yl)-1h-imidazo[4,5-b]pyrazin-2(3h)-one |
- |
- |
- |
- |
002 1件: 2 💬 |
14 |
[11c]mpc6827 |
- |
- |
- |
- |
002 1件: 2 💬 |
15 |
[18f] ge-180 |
- |
- |
- |
- |
002 1件: 2 💬 |
16 |
[18f]dpa-714 pet |
- |
- |
- |
- |
002 1件: 2 💬 |
17 |
[18f]pbr06 |
- |
- |
- |
- |
002 1件: 2 💬 |
18 |
[i-123] adam |
Iodide I-123 |
- |
- |
- |
002 1件: 2 💬 |
19 |
Ab1010 |
- |
- |
- |
- |
002 6件: 2 , 5 , 6 , 13, 46, 96 💬 |
20 |
Acetate |
Acetate |
- |
- |
- |
001 43件: 1 , 2 , 6 , 10, 13, 35, 40, 46, 49, 51, 60, 64, 67, 70, 71, 73, 75, 76, 78, 79, 81, 83, 85, 86, 88, 90, 96, 97, 113, 145, 156, 162, 171, 206, 222, 224, 225, 227, 235, 265, 288, 298, 299 💬 |
21 |
Acetylcarnitine |
Acetylcarnitine |
- |
- |
- |
002 2件: 2 , 265 💬 |
22 |
Acthar |
- |
- |
- |
- |
002 9件: 2 , 13, 14, 46, 49, 50, 66, 84, 222 💬 |
23 |
Actos 15 mg |
- |
- |
- |
- |
002 1件: 2 💬 |
24 |
Actos 30 mg |
- |
- |
- |
- |
002 1件: 2 💬 |
25 |
Actos 45 mg |
- |
- |
- |
- |
002 1件: 2 💬 |
26 |
Albumin |
- |
- |
- |
- |
002 3件: 2 , 20, 51 💬 |
27 |
Albutein 5% |
- |
- |
- |
- |
002 1件: 2 💬 |
28 |
Albúmina humana |
- |
- |
- |
- |
002 1件: 2 💬 |
29 |
Alpha-lipoic acid |
Lipoic acid |
2件: D00048 D00048, D00086 D00086 💬 |
- |
- |
002 2件: 2 , 13 💬 |
30 |
Alxn1210 |
- |
- |
- |
- |
002 5件: 2 , 11, 13, 62, 109 💬 |
31 |
Alzt-op1a (cromolyn) |
Cromoglicic acid |
2件: D00526 D00526, D07753 D07753 💬 |
- |
- |
002 1件: 2 💬 |
32 |
Amivita |
- |
- |
- |
- |
002 1件: 2 💬 |
33 |
Amsc |
- |
- |
- |
- |
002 1件: 2 💬 |
34 |
Amx0035 |
- |
- |
- |
- |
002 1件: 2 💬 |
35 |
Anakinra |
Anakinra |
1件: D02934 D02934 💬 |
IL1R1 2件: IL1R1, IL1R2 💬 |
Amoebiasis 15件: Amoebiasis, Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Inflammatory mediator regulation of TRP channels, MAPK signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Pathogenic Escherichia coli infection, Prostate cancer, Shigellosis, Th17 cell differentiation, Transcriptional misregulation in cancer |
002 17件: 2 , 13, 15, 19, 28, 37, 41, 46, 49, 50, 56, 84, 86, 97, 106, 107, 299 💬 |
36 |
Anx005 |
- |
- |
- |
- |
002 3件: 2 , 8 , 61 💬 |
37 |
Ap |
- |
- |
- |
- |
002 4件: 2 , 6 , 13, 299 💬 |
38 |
Ap-101 |
- |
- |
- |
- |
002 1件: 2 💬 |
39 |
Apo-p001 |
- |
- |
- |
- |
002 1件: 2 💬 |
40 |
Arimoclomol |
Arimoclomol |
1件: D11374 D11374 💬 |
- |
- |
002 3件: 2 , 15, 19 💬 |
41 |
Arundic acid |
Arundic acid |
1件: D06296 D06296 💬 |
- |
- |
002 1件: 2 💬 |
42 |
Astrorx |
- |
- |
- |
- |
002 1件: 2 💬 |
43 |
At-1501 |
- |
- |
- |
- |
002 1件: 2 💬 |
44 |
Atropine |
Atropine |
5件: D00113 D00113, D01077 D01077, D02069 D02069, D03011 D03011, D03814 D03814 💬 |
CHRM1 5件: CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬 |
Alzheimer disease 13件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway |
002 1件: 2 💬 |
45 |
Autologous adipose-derived mesenchymal stromal cells |
Human Umbilical Cord Mesenchymal Stem Cells |
- |
- |
- |
002 1件: 2 💬 |
46 |
Autologous adult bone marrow mononuclear cells (bm-mnc) unexpanded |
- |
- |
- |
- |
002 1件: 2 💬 |
47 |
Autologous adult bone marrow mononuclear cells unexpanded |
- |
- |
- |
- |
002 1件: 2 💬 |
48 |
Autologous bone marrow mononucleated cells |
- |
- |
- |
- |
002 1件: 2 💬 |
49 |
Autologous bone marrow-derived stem cells |
- |
- |
- |
- |
002 1件: 2 💬 |
50 |
Autologous mesenchymal stem cells |
- |
- |
- |
- |
002 5件: 2 , 6 , 13, 17, 46 💬 |
51 |
Autologous mesenchymal stem cells (mscs) |
- |
- |
- |
- |
002 1件: 2 💬 |
52 |
Autologous msc-ntf cells |
- |
- |
- |
- |
002 1件: 2 💬 |
53 |
Autologous t-regulatory lymphocytes |
- |
- |
- |
- |
002 1件: 2 💬 |
54 |
Avp-923 |
- |
- |
- |
- |
002 3件: 2 , 6 , 13 💬 |
55 |
Azilect |
- |
- |
- |
- |
002 4件: 2 , 5 , 6 , 17 💬 |
56 |
Azilect® 1 mg tabletten |
- |
- |
- |
- |
002 1件: 2 💬 |
57 |
Baclofen |
Baclofen |
1件: D00241 D00241 💬 |
GABBR1 2件: GABBR1, GABBR2 💬 |
Estrogen signaling pathway 7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway |
002 5件: 2 , 10, 13, 18, 149 💬 |
58 |
Basiliximab |
Basiliximab |
1件: D03058 D03058 💬 |
IL2RA 1件: IL2RA 💬 |
Cytokine-cytokine receptor interaction 11件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor |
002 6件: 2 , 50, 65, 97, 222, 228 💬 |
59 |
Behavioral: bci-fit active querying |
- |
- |
- |
- |
002 3件: 2 , 6 , 17 💬 |
60 |
Behavioral: bci-fit adaptive signal modeling |
- |
- |
- |
- |
002 3件: 2 , 6 , 17 💬 |
61 |
Behavioral: bci-fit language modeling |
- |
- |
- |
- |
002 3件: 2 , 6 , 17 💬 |
62 |
Behavioral: bci-fit multi-modal access |
- |
- |
- |
- |
002 3件: 2 , 6 , 17 💬 |
63 |
Betamethasone |
Betamethasone |
7件: D00244 D00244, D00972 D00972, D01357 D01357, D01402 D01402, D01637 D01637, D02032 D02032, D02286 D02286 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
002 6件: 2 , 28, 46, 90, 96, 235 💬 |
64 |
Betamethasone sodium phosphate/betamethasone acetate (celestone® soluspan®), 30 mg im once a day for four days |
Acetate |
7件: D00244 D00244, D00972 D00972, D01357 D01357, D01402 D01402, D01637 D01637, D02032 D02032, D02286 D02286 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
002 1件: 2 💬 |
65 |
Bhv-0223 |
- |
- |
- |
- |
002 1件: 2 💬 |
66 |
Biib050 / kns-760704 |
- |
- |
- |
- |
002 1件: 2 💬 |
67 |
Biib050/kns-760704 |
- |
- |
- |
- |
002 1件: 2 💬 |
68 |
Biib067 |
- |
- |
- |
- |
002 1件: 2 💬 |
69 |
Biib067 (isis666853) |
- |
- |
- |
- |
002 1件: 2 💬 |
70 |
Biib078 |
- |
- |
- |
- |
002 1件: 2 💬 |
71 |
Biib100 |
- |
- |
- |
- |
002 1件: 2 💬 |
72 |
Biib105 |
- |
- |
- |
- |
002 1件: 2 💬 |
73 |
Biologic: ic14 (monoclonal antibody against human cd14) |
- |
- |
- |
- |
002 1件: 2 💬 |
74 |
Biotin |
Biotin |
1件: D00029 D00029 💬 |
- |
- |
002 5件: 2 , 8 , 10, 13, 20 💬 |
75 |
Blood sample and environmental survey |
- |
- |
- |
- |
002 1件: 2 💬 |
76 |
Blz945 |
- |
- |
- |
- |
002 1件: 2 💬 |
77 |
Bosutinib |
Bosutinib |
1件: D03252 D03252 💬 |
ABL1 2件: ABL1, SRC 💬 |
Adherens junction 46件: Adherens junction, Axon guidance, Bacterial invasion of epithelial cells, Bladder cancer, C-type lectin receptor signaling pathway, Cell cycle, Chemokine signaling pathway, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endocytosis, Epithelial cell signaling in Helicobacter pylori infection, ErbB signaling pathway, Estrogen signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, GABAergic synapse, Gap junction, GnRH signaling pathway, Hepatitis B, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Inflammatory mediator regulation of TRP channels, Kaposi sarcoma-associated herpesvirus infection, MicroRNAs in cancer, Mitophagy - animal, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Oxytocin signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Platelet activation, Prolactin signaling pathway, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis, Thyroid hormone signaling pathway, Tight junction, Tuberculosis, VEGF signaling pathway, Viral carcinogenesis, Viral myocarditis, Yersinia infection |
002 2件: 2 , 67 💬 |
78 |
Botox |
- |
- |
- |
- |
002 6件: 2 , 6 , 13, 51, 149, 226 💬 |
79 |
Botox 100 unites allergan (pr1) |
- |
- |
- |
- |
002 1件: 2 💬 |
80 |
Botox injection |
- |
- |
- |
- |
002 1件: 2 💬 |
81 |
Botulinum toxin type a |
Botulinum toxin type A |
1件: D00783 D00783 💬 |
SNAP25 1件: SNAP25 💬 |
Insulin secretion 2件: Insulin secretion, Synaptic vesicle cycle |
002 10件: 2 , 5 , 6 , 7 , 13, 15, 17, 70, 113, 149 💬 |
82 |
Botulinum toxin type b |
Botulinum Toxin Type B |
1件: D02735 D02735 💬 |
SNAP25 1件: SNAP25 💬 |
Insulin secretion 2件: Insulin secretion, Synaptic vesicle cycle |
002 3件: 2 , 6 , 51 💬 |
83 |
Botulinum toxin type b (myobloc) |
Botulinum Toxin Type B |
1件: D02735 D02735 💬 |
SNAP25 1件: SNAP25 💬 |
Insulin secretion 2件: Insulin secretion, Synaptic vesicle cycle |
002 2件: 2 , 6 💬 |
84 |
Brx-345 |
- |
- |
- |
- |
002 2件: 2 , 15 💬 |
85 |
Butylphthalide |
Butylphthalide |
- |
- |
- |
002 4件: 2 , 6 , 18, 22 💬 |
86 |
Caffeine |
Caffeine |
2件: D00528 D00528, D01453 D01453 💬 |
ADORA1 11件: ADORA1, ADORA2A, PDE1B, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE5A 💬 |
Alcoholism 22件: Alcoholism, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Parkinson disease, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
002 9件: 2 , 6 , 13, 21, 46, 78, 96, 97, 265 💬 |
87 |
Calogen |
- |
- |
- |
- |
002 1件: 2 💬 |
88 |
Cannabis |
Medical Cannabis |
- |
- |
- |
002 8件: 2 , 6 , 13, 46, 90, 96, 97, 271 💬 |
89 |
Cannabis sativa extract oromucosal spray |
Medical Cannabis |
- |
- |
- |
002 1件: 2 💬 |
90 |
Cannabis, medical |
Medical Cannabis |
- |
- |
- |
002 5件: 2 , 6 , 13, 96, 97 💬 |
91 |
Capsaicin |
Capsaicin |
1件: D00250 D00250 💬 |
TRPV1 1件: TRPV1 💬 |
Inflammatory mediator regulation of TRP channels 2件: Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction |
002 5件: 2 , 6 , 19, 86, 226 💬 |
92 |
Capsaicin challenge |
Capsaicin |
1件: D00250 D00250 💬 |
TRPV1 1件: TRPV1 💬 |
Inflammatory mediator regulation of TRP channels 2件: Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction |
002 1件: 2 💬 |
93 |
Carbidopa |
Carbidopa |
1件: D00558 D00558 💬 |
DDC 1件: DDC 💬 |
Alcoholism 9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism |
002 9件: 2 , 4 , 6 , 13, 17, 90, 140, 164, 201 💬 |
94 |
Carbidopa-levodopa |
Carbidopa |
2件: D00059 D00059, D00558 D00558 💬 |
DDC 6件: DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism 16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
002 3件: 2 , 4 , 6 💬 |
95 |
Carbolithium |
- |
- |
- |
- |
002 1件: 2 💬 |
96 |
Carbolithium*100cps 150mg |
- |
- |
- |
- |
002 1件: 2 💬 |
97 |
Carbonate |
Carbonate ion |
- |
- |
- |
002 12件: 2 , 13, 17, 18, 19, 46, 53, 75, 96, 127, 235, 299 💬 |
98 |
Carbonate de lithium |
Carbonate ion |
- |
- |
- |
002 1件: 2 💬 |
99 |
Cbd |
- |
- |
- |
- |
002 11件: 2 , 6 , 8 , 13, 46, 140, 144, 145, 156, 158, 206 💬 |
100 |
Cc100 |
- |
- |
- |
- |
002 1件: 2 💬 |
101 |
Ceftriaxone |
Ceftriaxone |
2件: D00924 D00924, D07659 D07659 💬 |
- |
- |
002 3件: 2 , 6 , 97 💬 |
102 |
Celecoxib |
Celecoxib |
1件: D00567 D00567 💬 |
PTGS2 1件: PTGS2 💬 |
Alzheimer disease 22件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
002 9件: 2 , 3 , 34, 46, 70, 89, 161, 171, 271 💬 |
103 |
Cell-based therapeutics |
- |
- |
- |
- |
002 1件: 2 💬 |
104 |
Cell-based therapy |
- |
- |
- |
- |
002 1件: 2 💬 |
105 |
Cell-based therapy of autologous adipose derived regenerative cells transplanted intraspinally and intrathecally in als patients |
- |
- |
- |
- |
002 1件: 2 💬 |
106 |
Cimetidine |
Cimetidine |
2件: D00295 D00295, D03503 D03503 💬 |
HRH2 1件: HRH2 💬 |
Calcium signaling pathway 3件: Calcium signaling pathway, Gastric acid secretion, Neuroactive ligand-receptor interaction |
002 1件: 2 💬 |
107 |
Cimetidine plus dexpramipexole |
Cimetidine |
3件: D00295 D00295, D03503 D03503, D09886 D09886 💬 |
DRD1 6件: DRD1, DRD2, DRD3, DRD4, DRD5, HRH2 💬 |
Alcoholism 12件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Gastric acid secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
002 1件: 2 💬 |
108 |
Ciprofloxacin |
Ciprofloxacin |
2件: D00186 D00186, D02216 D02216 💬 |
- |
- |
002 5件: 2 , 60, 96, 97, 299 💬 |
109 |
Cistanche total glycosides |
- |
- |
- |
- |
002 1件: 2 💬 |
110 |
Ck-2017357 |
- |
- |
- |
- |
002 1件: 2 💬 |
111 |
Ck-2017357 (part a) |
- |
- |
- |
- |
002 1件: 2 💬 |
112 |
Ck-2017357 (part b) |
- |
- |
- |
- |
002 1件: 2 💬 |
113 |
Ck-2127107 |
Reldesemtiv |
1件: D11363 D11363 💬 |
TNNC2 1件: TNNC2 💬 |
Calcium signaling pathway 1件: Calcium signaling pathway |
002 1件: 2 💬 |
114 |
Ck2017357 |
- |
- |
- |
- |
002 1件: 2 💬 |
115 |
Clenbuterol |
Clenbuterol |
1件: D07713 D07713 💬 |
ADRB2 1件: ADRB2 💬 |
Adrenergic signaling in cardiomyocytes 8件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway |
001 4件: 1 , 2 , 6 , 256 💬 |
116 |
Cnm-au8 |
- |
- |
- |
- |
002 2件: 2 , 13 💬 |
117 |
Coenzyme q10 |
Ubidecarenone |
1件: D01065 D01065 💬 |
- |
- |
002 12件: 2 , 5 , 6 , 8 , 10, 18, 46, 57, 113, 193, 214, 215 💬 |
118 |
Colchicina |
Colchicine |
1件: D00570 D00570 💬 |
TUBB 9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 |
Alzheimer disease 10件: Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection |
002 1件: 2 💬 |
119 |
Colchicina lirca - 1 mg compresse 60 compresse |
Colchicine |
1件: D00570 D00570 💬 |
TUBB 9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 |
Alzheimer disease 10件: Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection |
002 1件: 2 💬 |
120 |
Colchicine |
Colchicine |
1件: D00570 D00570 💬 |
TUBB 9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 |
Alzheimer disease 10件: Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection |
002 7件: 2 , 42, 46, 56, 93, 210, 266 💬 |
121 |
Colchicine 1 mg oral tablet |
Colchicine |
1件: D00570 D00570 💬 |
TUBB 9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 |
Alzheimer disease 10件: Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection |
002 1件: 2 💬 |
122 |
Combination product: active treatment with dual therapy |
- |
- |
- |
- |
002 1件: 2 💬 |
123 |
Control group |
- |
- |
- |
- |
002 3件: 2 , 46, 70 💬 |
124 |
Copegus |
- |
- |
- |
- |
002 1件: 2 💬 |
125 |
Copper |
Copper |
- |
- |
- |
002 4件: 2 , 169, 170, 171 💬 |
126 |
Cord blood therapy |
Umbilical Cord Blood Hematopoietic Stem Cells |
- |
- |
- |
002 2件: 2 , 6 💬 |
127 |
Corticotropin |
Corticotropin |
1件: D00146 D00146 💬 |
MC2R 1件: MC2R 💬 |
Aldosterone synthesis and secretion 5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
002 7件: 2 , 13, 46, 75, 78, 84, 222 💬 |
128 |
Creatine |
Creatine |
- |
- |
- |
001 12件: 1 , 2 , 5 , 6 , 8 , 13, 46, 49, 50, 113, 156, 201 💬 |
129 |
Creatine monohydrate |
Creatine |
- |
- |
- |
002 4件: 2 , 8 , 113, 156 💬 |
130 |
Creatinine |
Creatinine |
1件: D03600 D03600 💬 |
- |
- |
002 4件: 2 , 46, 60, 70 💬 |
131 |
Cromolyn |
Cromoglicic acid |
2件: D00526 D00526, D07753 D07753 💬 |
- |
- |
002 3件: 2 , 85, 98 💬 |
132 |
Cu(ii)atsm |
- |
- |
- |
- |
002 2件: 2 , 6 💬 |
133 |
Curcumin |
Curcumin |
- |
- |
- |
002 11件: 2 , 13, 46, 49, 67, 74, 94, 96, 97, 139, 299 💬 |
134 |
Células madre mesenquimales de tejido adiposo autólogo |
- |
- |
- |
- |
002 1件: 2 💬 |
135 |
Células mesenquimales de tejido adiposo |
- |
- |
- |
- |
002 1件: 2 💬 |
136 |
Células troncales hematopoyéticas autólogas adultas extraidas de médula ósea |
- |
- |
- |
- |
002 1件: 2 💬 |
137 |
Daraprim |
- |
- |
- |
- |
002 2件: 2 , 4 💬 |
138 |
Darunavir |
Darunavir |
1件: D03656 D03656 💬 |
- |
- |
002 1件: 2 💬 |
139 |
Datscan |
- |
- |
- |
- |
002 4件: 2 , 5 , 6 , 17 💬 |
140 |
Deferiprone |
Deferiprone |
1件: D07416 D07416 💬 |
- |
- |
002 6件: 2 , 6 , 18, 120, 122, 233 💬 |
141 |
Device: electrical impedance myography |
- |
- |
- |
- |
002 1件: 2 💬 |
142 |
Device: iowa oral performance instrument |
- |
- |
- |
- |
002 1件: 2 💬 |
143 |
Device: iowa oral pressure instrument |
- |
- |
- |
- |
002 1件: 2 💬 |
144 |
Device: micro mouth pressure meter |
- |
- |
- |
- |
002 1件: 2 💬 |
145 |
Device: powerlung trainer |
- |
- |
- |
- |
002 1件: 2 💬 |
146 |
Device: pulmonary function testing |
- |
- |
- |
- |
002 1件: 2 💬 |
147 |
Device: stereotactic surgical device |
- |
- |
- |
- |
002 1件: 2 💬 |
148 |
Device: voluntary peak cough flow testing |
- |
- |
- |
- |
002 1件: 2 💬 |
149 |
Dexdor |
- |
- |
- |
- |
002 4件: 2 , 4 , 6 , 70 💬 |
150 |
Dexmedetomidine |
Dexmedetomidine |
2件: D00514 D00514, D01205 D01205 💬 |
ADRA2A 3件: ADRA2A, ADRA2B, ADRA2C 💬 |
Neuroactive ligand-receptor interaction 2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway |
002 12件: 2 , 4 , 6 , 21, 34, 46, 70, 113, 212, 215, 226, 280 💬 |
151 |
Dexpramipexole |
Dexpramipexole |
1件: D09886 D09886 💬 |
DRD1 5件: DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
002 1件: 2 💬 |
152 |
Dexpramipexole (dose 1) |
Dexpramipexole |
1件: D09886 D09886 💬 |
DRD1 5件: DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
002 1件: 2 💬 |
153 |
Dexpramipexole (dose 2) |
Dexpramipexole |
1件: D09886 D09886 💬 |
DRD1 5件: DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
002 1件: 2 💬 |
154 |
Dexpramipexole dichydrochloride |
Dexpramipexole |
1件: D09886 D09886 💬 |
DRD1 5件: DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
002 1件: 2 💬 |
155 |
Dexpramipexole dihydrochloride |
Dexpramipexole |
1件: D09886 D09886 💬 |
DRD1 5件: DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
002 1件: 2 💬 |
156 |
Dextran |
Dextran |
1件: D00060 D00060 💬 |
- |
- |
002 5件: 2 , 62, 79, 96, 97 💬 |
157 |
Dextran sodium sulfur salt 5, mw 5 kda. a type of low molecular weight dextran sulfate (lmw-ds) |
Dextran |
1件: D00060 D00060 💬 |
- |
- |
002 1件: 2 💬 |
158 |
Dextran sulfate sodium |
Dextran |
1件: D00060 D00060 💬 |
- |
- |
002 1件: 2 💬 |
159 |
Dextromethorphan |
Dextromethorphan |
3件: D00848 D00848, D03742 D03742, D03744 D03744 💬 |
GRIN1 6件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SIGMAR1 💬 |
Alcoholism 20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway |
002 11件: 2 , 6 , 8 , 13, 21, 46, 78, 85, 96, 97, 156 💬 |
160 |
Dextromethorphan hbr and quinidine sulfate |
Dextromethorphan |
7件: D00642 D00642, D00643 D00643, D00848 D00848, D02272 D02272, D03742 D03742, D03744 D03744, D08458 D08458 💬 |
GRIN1 11件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A, SIGMAR1 💬 |
Adrenergic signaling in cardiomyocytes 22件: Adrenergic signaling in cardiomyocytes, Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, Taste transduction, cAMP signaling pathway |
002 1件: 2 💬 |
161 |
Dextromethorphan hydrobromide 20 mg and quinidine sulfate 10 mg |
Dextromethorphan |
7件: D00642 D00642, D00643 D00643, D00848 D00848, D02272 D02272, D03742 D03742, D03744 D03744, D08458 D08458 💬 |
GRIN1 11件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A, SIGMAR1 💬 |
Adrenergic signaling in cardiomyocytes 22件: Adrenergic signaling in cardiomyocytes, Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, Taste transduction, cAMP signaling pathway |
002 2件: 2 , 13 💬 |
162 |
Dextromethorphan hydrobromide 30 mg and quinidine sulfate 10 mg |
Dextromethorphan |
7件: D00642 D00642, D00643 D00643, D00848 D00848, D02272 D02272, D03742 D03742, D03744 D03744, D08458 D08458 💬 |
GRIN1 11件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A, SIGMAR1 💬 |
Adrenergic signaling in cardiomyocytes 22件: Adrenergic signaling in cardiomyocytes, Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, Taste transduction, cAMP signaling pathway |
002 2件: 2 , 13 💬 |
163 |
Dnl747 |
- |
- |
- |
- |
002 1件: 2 💬 |
164 |
Dolutegravir |
Dolutegravir |
1件: D10066 D10066 💬 |
- |
- |
002 2件: 2 , 265 💬 |
165 |
Dpa |
- |
- |
- |
- |
002 4件: 2 , 6 , 13, 85 💬 |
166 |
Dronabinol |
Dronabinol |
1件: D00306 D00306 💬 |
CNR1 2件: CNR1, CNR2 💬 |
Neuroactive ligand-receptor interaction 4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis |
002 5件: 2 , 13, 46, 271, 298 💬 |
167 |
Drug: f 18 t807 |
- |
- |
- |
- |
002 1件: 2 💬 |
168 |
Dutasteride |
Dutasteride |
1件: D03820 D03820 💬 |
SRD5A1 2件: SRD5A1, SRD5A2 💬 |
Prostate cancer 2件: Prostate cancer, Steroid hormone biosynthesis |
001 2件: 1 , 2 💬 |
169 |
Dutasteride 0.5 mg |
Dutasteride |
1件: D03820 D03820 💬 |
SRD5A1 2件: SRD5A1, SRD5A2 💬 |
Prostate cancer 2件: Prostate cancer, Steroid hormone biosynthesis |
002 1件: 2 💬 |
170 |
E0302 (mecobalamin) |
Mecobalamin |
1件: D03246 D03246 💬 |
- |
- |
002 1件: 2 💬 |
171 |
Ebixa |
- |
- |
- |
- |
002 3件: 2 , 6 , 13 💬 |
172 |
Edaravone |
Edaravone |
1件: D01552 D01552 💬 |
- |
- |
002 2件: 2 , 22 💬 |
173 |
Eh301 (nicotinamide riboside/pterostilbene) |
Nicotinamide |
1件: D00036 D00036 💬 |
- |
- |
002 1件: 2 💬 |
174 |
Endocannabinoid palmitoylethanolamide (pea) |
Palmidrol |
1件: D08328 D08328 💬 |
- |
- |
002 1件: 2 💬 |
175 |
Engensis |
- |
- |
- |
- |
002 1件: 2 💬 |
176 |
Eperisone |
Eperisone |
2件: D01671 D01671, D07898 D07898 💬 |
- |
- |
002 1件: 2 💬 |
177 |
Epi-589 |
EPI-589 |
- |
- |
- |
002 2件: 2 , 6 💬 |
178 |
Eprex iv sc 1fl 1ml 40000 ui |
- |
- |
- |
- |
002 1件: 2 💬 |
179 |
Eprex*1sir 40000ui/ml 1ml |
- |
- |
- |
- |
002 2件: 2 , 18 💬 |
180 |
Eril® |
- |
- |
- |
- |
002 1件: 2 💬 |
181 |
Erythropoetin (epo) |
- |
- |
- |
- |
002 1件: 2 💬 |
182 |
Erythropoietin |
Erythropoietin |
1件: D03231 D03231 💬 |
EPOR 1件: EPOR 💬 |
Cytokine-cytokine receptor interaction 5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer |
002 9件: 2 , 6 , 13, 18, 22, 47, 70, 95, 96 💬 |
183 |
Escitalopram |
Escitalopram |
3件: D02567 D02567, D07704 D07704, D07913 D07913 💬 |
SLC6A4 1件: SLC6A4 💬 |
Serotonergic synapse 2件: Serotonergic synapse, Synaptic vesicle cycle |
002 3件: 2 , 6 , 13 💬 |
184 |
Esketamine |
Esketamine |
1件: D07283 D07283 💬 |
GRIN1 5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 |
Alcoholism 20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway |
002 3件: 2 , 4 , 70 💬 |
185 |
Ezogabine |
Ezogabine |
1件: D09569 D09569 💬 |
KCNQ1 5件: KCNQ1, KCNQ2, KCNQ3, KCNQ4, KCNQ5 💬 |
Adrenergic signaling in cardiomyocytes 6件: Adrenergic signaling in cardiomyocytes, Cholinergic synapse, Gastric acid secretion, Pancreatic secretion, Protein digestion and absorption, Vibrio cholerae infection |
002 2件: 2 , 144 💬 |
186 |
Fasudil |
Fasudil |
1件: D07941 D07941 💬 |
ROCK1 2件: ROCK1, ROCK2 💬 |
Axon guidance 22件: Axon guidance, Chemokine signaling pathway, Focal adhesion, Human cytomegalovirus infection, Leukocyte transendothelial migration, MicroRNAs in cancer, Oxytocin signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Platelet activation, Proteoglycans in cancer, Regulation of actin cytoskeleton, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, TGF-beta signaling pathway, Tight junction, Vascular smooth muscle contraction, Wnt signaling pathway, Yersinia infection, cAMP signaling pathway, cGMP-PKG signaling pathway |
002 2件: 2 , 51 💬 |
187 |
Fasudil hydrochloride |
Fasudil |
1件: D07941 D07941 💬 |
ROCK1 2件: ROCK1, ROCK2 💬 |
Axon guidance 22件: Axon guidance, Chemokine signaling pathway, Focal adhesion, Human cytomegalovirus infection, Leukocyte transendothelial migration, MicroRNAs in cancer, Oxytocin signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Platelet activation, Proteoglycans in cancer, Regulation of actin cytoskeleton, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, TGF-beta signaling pathway, Tight junction, Vascular smooth muscle contraction, Wnt signaling pathway, Yersinia infection, cAMP signaling pathway, cGMP-PKG signaling pathway |
002 1件: 2 💬 |
188 |
Febuxostat |
Febuxostat |
1件: D01206 D01206 💬 |
XDH 1件: XDH 💬 |
Caffeine metabolism 5件: Caffeine metabolism, Drug metabolism - other enzymes, Metabolic pathways, Peroxisome, Purine metabolism |
002 3件: 2 , 6 , 13 💬 |
189 |
Fecal microbiota transplantation |
- |
- |
- |
- |
002 5件: 2 , 66, 94, 96, 97 💬 |
190 |
Fig |
Fig |
- |
- |
- |
002 1件: 2 💬 |
191 |
Filgrastim |
Filgrastim |
1件: D03235 D03235 💬 |
CSF3R 1件: CSF3R 💬 |
Cytokine-cytokine receptor interaction 5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer |
002 27件: 2 , 6 , 13, 25, 26, 28, 34, 35, 40, 41, 42, 45, 46, 49, 51, 60, 62, 65, 96, 113, 164, 256, 283, 284, 285, 296, 331 💬 |
192 |
Fixed dose combination ciprofloxacin/celecoxib |
Celecoxib |
3件: D00186 D00186, D00567 D00567, D02216 D02216 💬 |
PTGS2 1件: PTGS2 💬 |
Alzheimer disease 22件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
002 1件: 2 💬 |
193 |
Flx-787-odt |
- |
- |
- |
- |
002 1件: 2 💬 |
194 |
Flx-787-odt (orally disintigrating tablet) |
- |
- |
- |
- |
002 1件: 2 💬 |
195 |
Fycompa |
- |
- |
- |
- |
002 2件: 2 , 144 💬 |
196 |
G-csf |
Filgrastim |
1件: D03235 D03235 💬 |
CSF3R 1件: CSF3R 💬 |
Cytokine-cytokine receptor interaction 5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer |
002 16件: 2 , 6 , 11, 13, 16, 47, 49, 51, 60, 62, 65, 85, 96, 284, 285, 331 💬 |
197 |
Gdc-0134 |
- |
- |
- |
- |
002 1件: 2 💬 |
198 |
Gilenya |
- |
- |
- |
- |
002 3件: 2 , 13, 14 💬 |
199 |
Glatiramer |
Glatiramer |
1件: D04318 D04318 💬 |
HLA-A 20件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬 |
Allograft rejection 32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis |
002 4件: 2 , 13, 96, 156 💬 |
200 |
Glucose |
Dextrose, unspecified form |
- |
- |
- |
002 15件: 2 , 6 , 13, 49, 50, 65, 75, 86, 88, 96, 160, 195, 254, 257, 299 💬 |
201 |
Gm604 |
- |
- |
- |
- |
002 1件: 2 💬 |
202 |
Gold |
Gold |
- |
- |
- |
002 38件: 2 , 5 , 6 , 13, 17, 34, 46, 49, 50, 53, 65, 68, 76, 84, 86, 91, 93, 95, 96, 97, 98, 113, 158, 162, 171, 218, 222, 224, 227, 230, 271, 291, 294, 296, 298, 299, 310, 318 💬 |
203 |
Gold nanocrystals |
Gold |
- |
- |
- |
002 3件: 2 , 6 , 13 💬 |
204 |
Granulocyte - colony stimulating factor (g-csf) |
Filgrastim |
1件: D03235 D03235 💬 |
CSF3R 1件: CSF3R 💬 |
Cytokine-cytokine receptor interaction 5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer |
002 1件: 2 💬 |
205 |
Granulocyte colony stimulating factor |
Filgrastim |
1件: D03235 D03235 💬 |
CSF3R 1件: CSF3R 💬 |
Cytokine-cytokine receptor interaction 5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer |
002 6件: 2 , 28, 36, 57, 65, 85 💬 |
206 |
Growth hormone |
Somatotropin |
1件: D02691 D02691 💬 |
GHR 1件: GHR 💬 |
Cytokine-cytokine receptor interaction 5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
002 12件: 2 , 13, 19, 46, 78, 96, 187, 191, 193, 195, 265, 299 💬 |
207 |
Growth hormone (somatropin) |
Somatotropin |
1件: D02691 D02691 💬 |
GHR 1件: GHR 💬 |
Cytokine-cytokine receptor interaction 5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
002 2件: 2 , 78 💬 |
208 |
Gsk1223249 |
- |
- |
- |
- |
002 2件: 2 , 13 💬 |
209 |
Guana2015 |
- |
- |
- |
- |
002 1件: 2 💬 |
210 |
Guanabenz |
Guanabenz |
1件: D04375 D04375 💬 |
ADRA2A 3件: ADRA2A, ADRA2B, ADRA2C 💬 |
Neuroactive ligand-receptor interaction 2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway |
002 2件: 2 , 13 💬 |
211 |
Guanabenz acetato |
Guanabenz |
1件: D04375 D04375 💬 |
ADRA2A 3件: ADRA2A, ADRA2B, ADRA2C 💬 |
Neuroactive ligand-receptor interaction 2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway |
002 1件: 2 💬 |
212 |
Hb-admscs |
Adipose-Derived Mesenchymal Stem Cells: Autologous or Allogeneic Origins |
- |
- |
- |
002 3件: 2 , 6 , 46 💬 |
213 |
High-caloric fatty diet |
- |
- |
- |
- |
002 1件: 2 💬 |
214 |
Hk-001 |
- |
- |
- |
- |
002 1件: 2 💬 |
215 |
Human albumin |
Albumin human |
2件: D02792 D02792, D05424 D05424 💬 |
- |
- |
002 2件: 2 , 96 💬 |
216 |
Human albumin solution |
Albumin human |
2件: D02792 D02792, D05424 D05424 💬 |
- |
- |
002 1件: 2 💬 |
217 |
Human autologous mesenchymal stem cells |
- |
- |
- |
- |
002 2件: 2 , 13 💬 |
218 |
Human neural stem cells |
- |
- |
- |
- |
002 2件: 2 , 13 💬 |
219 |
Hynr-cs inj |
- |
- |
- |
- |
002 1件: 2 💬 |
220 |
Hynrcs-allo inj |
- |
- |
- |
- |
002 1件: 2 💬 |
221 |
Hyperpolarized [1-13c]pyruvate |
- |
- |
- |
- |
002 1件: 2 💬 |
222 |
I-123 |
Iodide I-123 |
- |
- |
- |
002 2件: 2 , 6 💬 |
223 |
Ibudilast |
Ibudilast |
1件: D01385 D01385 💬 |
CYSLTR1 8件: CYSLTR1, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PTGIR 💬 |
Apelin signaling pathway 16件: Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action, Platelet activation, Progesterone-mediated oocyte maturation, Purine metabolism, Regulation of lipolysis in adipocytes, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
002 2件: 2 , 13 💬 |
224 |
Ic14 |
- |
- |
- |
- |
002 1件: 2 💬 |
225 |
Il-2 |
Human interleukin-2 |
- |
- |
- |
002 6件: 2 , 46, 49, 53, 56, 96 💬 |
226 |
Ilb |
- |
- |
- |
- |
002 1件: 2 💬 |
227 |
Ilb: 100mg/ml solution for injection and infusion |
- |
- |
- |
- |
002 1件: 2 💬 |
228 |
Immunoglobulin g1, anti (protein nogo a) (human mus musculus monoclonal heavy |
- |
- |
- |
- |
002 1件: 2 💬 |
229 |
Immunoglobulin g1, anti (protein nogo a) (human mus musculus monoclonal heavy chain), disulfide with human mus musculus monoclonal light chain, dimer |
- |
- |
- |
- |
002 1件: 2 💬 |
230 |
Incobotulinum toxin a |
- |
- |
- |
- |
002 3件: 2 , 6 , 13 💬 |
231 |
Inosine |
Inosine |
1件: D00054 D00054 💬 |
- |
- |
002 4件: 2 , 6 , 13, 17 💬 |
232 |
Insulin like growth factor, type 1 |
- |
- |
- |
- |
002 1件: 2 💬 |
233 |
Interleukin-2 |
Human interleukin-2 |
- |
- |
- |
002 8件: 2 , 35, 49, 55, 65, 96, 97, 162 💬 |
234 |
Intra venous injection of stem cell |
- |
- |
- |
- |
002 1件: 2 💬 |
235 |
Intrathecal autologous stem cell |
- |
- |
- |
- |
002 1件: 2 💬 |
236 |
Intrathecal injection |
- |
- |
- |
- |
002 1件: 2 💬 |
237 |
Intravenous administration of 1 million of msc |
- |
- |
- |
- |
002 1件: 2 💬 |
238 |
Intravenous administration of 2 million of msc |
- |
- |
- |
- |
002 1件: 2 💬 |
239 |
Intravenous administration of 4 million of msc |
- |
- |
- |
- |
002 1件: 2 💬 |
240 |
Intraventricular injection |
- |
- |
- |
- |
002 1件: 2 💬 |
241 |
Ioflupane 123i |
- |
- |
- |
- |
002 1件: 2 💬 |
242 |
Ipl344 |
- |
- |
- |
- |
002 1件: 2 💬 |
243 |
Isis 333611 |
- |
- |
- |
- |
002 1件: 2 💬 |
244 |
Isocaloric diet |
- |
- |
- |
- |
002 2件: 2 , 83 💬 |
245 |
Jevity 1.0 |
- |
- |
- |
- |
002 1件: 2 💬 |
246 |
Jevity 1.5 |
- |
- |
- |
- |
002 1件: 2 💬 |
247 |
Ketanest |
- |
- |
- |
- |
002 3件: 2 , 4 , 70 💬 |
248 |
Ketanest-s |
- |
- |
- |
- |
002 3件: 2 , 4 , 70 💬 |
249 |
Ketocal |
- |
- |
- |
- |
002 1件: 2 💬 |
250 |
Kns-760704 |
- |
- |
- |
- |
002 1件: 2 💬 |
251 |
L-serine |
Serine |
1件: D00016 D00016 💬 |
- |
- |
002 1件: 2 💬 |
252 |
Lacosamide |
Lacosamide |
1件: D07299 D07299 💬 |
SCN3A 2件: SCN3A, SCN9A 💬 |
Taste transduction 1件: Taste transduction |
002 3件: 2 , 46, 149 💬 |
253 |
Lactose |
Lactose |
2件: D00046 D00046, D03226 D03226 💬 |
- |
- |
002 6件: 2 , 6 , 13, 97, 228, 310 💬 |
254 |
Lenograstim |
Lenograstim |
1件: D03247 D03247 💬 |
CSF3R 1件: CSF3R 💬 |
Cytokine-cytokine receptor interaction 5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer |
002 7件: 2 , 13, 16, 18, 19, 57, 65 💬 |
255 |
Leuprolide |
Leuprolide |
2件: D00989 D00989, D08113 D08113 💬 |
GNRHR 1件: GNRHR 💬 |
GnRH signaling pathway 2件: GnRH signaling pathway, Neuroactive ligand-receptor interaction |
001 5件: 1 , 2 , 3 , 51, 76 💬 |
256 |
Levetiracetam |
Levetiracetam |
1件: D00709 D00709 💬 |
SV2A 1件: SV2A 💬 |
ECM-receptor interaction 1件: ECM-receptor interaction |
002 4件: 2 , 4 , 6 , 13 💬 |
257 |
Levodopa |
Levodopa |
1件: D00059 D00059 💬 |
DRD1 5件: DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
002 8件: 2 , 4 , 6 , 17, 90, 140, 164, 201 💬 |
258 |
Levosimendan |
Levosimendan |
1件: D04720 D04720 💬 |
PDE3A 2件: PDE3A, PDE3B 💬 |
Apelin signaling pathway 11件: Apelin signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Progesterone-mediated oocyte maturation, Purine metabolism, Regulation of lipolysis in adipocytes, Renin secretion, cAMP signaling pathway, cGMP-PKG signaling pathway |
002 1件: 2 💬 |
259 |
Lioresal*50cpr 10mg |
- |
- |
- |
- |
002 1件: 2 💬 |
260 |
Lipoic acid |
Lipoic acid |
2件: D00048 D00048, D00086 D00086 💬 |
- |
- |
002 5件: 2 , 5 , 13, 14, 20 💬 |
261 |
Lipoic acid group |
Lipoic acid |
2件: D00048 D00048, D00086 D00086 💬 |
- |
- |
002 1件: 2 💬 |
262 |
Liposomed polyphenols resveratrol and curcumin |
Curcumin |
- |
- |
- |
002 1件: 2 💬 |
263 |
Lithium |
- |
- |
- |
- |
002 5件: 2 , 5 , 6 , 7 , 8 💬 |
264 |
Lithium apogepha |
- |
- |
- |
- |
002 1件: 2 💬 |
265 |
Lithium carbonate |
Carbonate ion |
1件: D00801 D00801 💬 |
- |
- |
002 6件: 2 , 13, 17, 18, 19, 127 💬 |
266 |
Lithium citrate |
Lithium citrate |
1件: D04749 D04749 💬 |
- |
- |
002 1件: 2 💬 |
267 |
Lithiumcarbonaat |
- |
- |
- |
- |
002 1件: 2 💬 |
268 |
Lithiumcarbonaat 400 pch tabletten |
- |
- |
- |
- |
002 1件: 2 💬 |
269 |
Litio carbonato |
- |
- |
- |
- |
002 2件: 2 , 17 💬 |
270 |
Lunasin |
Lunasine |
- |
- |
- |
002 1件: 2 💬 |
271 |
Lunasin regimen |
Lunasine |
- |
- |
- |
002 1件: 2 💬 |
272 |
Mannitolo 18% |
- |
- |
- |
- |
002 1件: 2 💬 |
273 |
Mannitolo 18% ldb |
- |
- |
- |
- |
002 1件: 2 💬 |
274 |
Masitinib |
Masitinib |
1件: D10229 D10229 💬 |
KIT 1件: KIT 💬 |
Acute myeloid leukemia 11件: Acute myeloid leukemia, Breast cancer, Central carbon metabolism in cancer, Hematopoietic cell lineage, MAPK signaling pathway, Melanogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway |
002 6件: 2 , 5 , 6 , 13, 46, 96 💬 |
275 |
Masitinib (3.0) |
Masitinib |
1件: D10229 D10229 💬 |
KIT 1件: KIT 💬 |
Acute myeloid leukemia 11件: Acute myeloid leukemia, Breast cancer, Central carbon metabolism in cancer, Hematopoietic cell lineage, MAPK signaling pathway, Melanogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway |
002 1件: 2 💬 |
276 |
Masitinib (4.5) |
Masitinib |
1件: D10229 D10229 💬 |
KIT 1件: KIT 💬 |
Acute myeloid leukemia 11件: Acute myeloid leukemia, Breast cancer, Central carbon metabolism in cancer, Hematopoietic cell lineage, MAPK signaling pathway, Melanogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway |
002 1件: 2 💬 |
277 |
Masitinib (6.0) |
Masitinib |
1件: D10229 D10229 💬 |
KIT 1件: KIT 💬 |
Acute myeloid leukemia 11件: Acute myeloid leukemia, Breast cancer, Central carbon metabolism in cancer, Hematopoietic cell lineage, MAPK signaling pathway, Melanogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway |
002 1件: 2 💬 |
278 |
Masitinib 100 mg tablets |
Masitinib |
1件: D10229 D10229 💬 |
KIT 1件: KIT 💬 |
Acute myeloid leukemia 11件: Acute myeloid leukemia, Breast cancer, Central carbon metabolism in cancer, Hematopoietic cell lineage, MAPK signaling pathway, Melanogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway |
002 1件: 2 💬 |
279 |
Masitinib 100mg |
Masitinib |
1件: D10229 D10229 💬 |
KIT 1件: KIT 💬 |
Acute myeloid leukemia 11件: Acute myeloid leukemia, Breast cancer, Central carbon metabolism in cancer, Hematopoietic cell lineage, MAPK signaling pathway, Melanogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway |
002 2件: 2 , 5 💬 |
280 |
Masitinib 200 mg tablets |
Masitinib |
1件: D10229 D10229 💬 |
KIT 1件: KIT 💬 |
Acute myeloid leukemia 11件: Acute myeloid leukemia, Breast cancer, Central carbon metabolism in cancer, Hematopoietic cell lineage, MAPK signaling pathway, Melanogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway |
002 1件: 2 💬 |
281 |
Masitinib 200mg |
Masitinib |
1件: D10229 D10229 💬 |
KIT 1件: KIT 💬 |
Acute myeloid leukemia 11件: Acute myeloid leukemia, Breast cancer, Central carbon metabolism in cancer, Hematopoietic cell lineage, MAPK signaling pathway, Melanogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway |
002 2件: 2 , 5 💬 |
282 |
Masitinib mesylate |
Masitinib |
1件: D10229 D10229 💬 |
KIT 1件: KIT 💬 |
Acute myeloid leukemia 11件: Acute myeloid leukemia, Breast cancer, Central carbon metabolism in cancer, Hematopoietic cell lineage, MAPK signaling pathway, Melanogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway |
002 6件: 2 , 5 , 6 , 13, 46, 96 💬 |
283 |
Mci-186 |
- |
- |
- |
- |
002 1件: 2 💬 |
284 |
Mci-186 in open label phase |
- |
- |
- |
- |
002 1件: 2 💬 |
285 |
Md1003 |
- |
- |
- |
- |
002 5件: 2 , 10, 13, 14, 20 💬 |
286 |
Mecobalamin |
Mecobalamin |
1件: D03246 D03246 💬 |
- |
- |
002 1件: 2 💬 |
287 |
Medicabilis cbd oil |
- |
- |
- |
- |
002 1件: 2 💬 |
288 |
Medicine |
- |
- |
- |
- |
002 1件: 2 💬 |
289 |
Memantine |
Memantine |
2件: D04905 D04905, D08174 D08174 💬 |
GRIN1 5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 |
Alcoholism 20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway |
002 7件: 2 , 6 , 8 , 13, 49, 127, 205 💬 |
290 |
Memantine (ebixa) |
Memantine |
2件: D04905 D04905, D08174 D08174 💬 |
GRIN1 5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 |
Alcoholism 20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway |
002 1件: 2 💬 |
291 |
Memantine hydrochloride |
Memantine |
2件: D04905 D04905, D08174 D08174 💬 |
GRIN1 5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 |
Alcoholism 20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway |
002 3件: 2 , 6 , 127 💬 |
292 |
Memantine hydrochloride oral solution |
Memantine |
2件: D04905 D04905, D08174 D08174 💬 |
GRIN1 5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 |
Alcoholism 20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway |
002 1件: 2 💬 |
293 |
Mesenchymal stem cell |
- |
- |
- |
- |
002 1件: 2 💬 |
294 |
Mesenchymal stem cells |
- |
- |
- |
- |
002 11件: 2 , 6 , 13, 20, 49, 51, 60, 96, 222, 274, 299 💬 |
295 |
Mesenchymal stem cells isolated from wharton's jelly |
- |
- |
- |
- |
002 1件: 2 💬 |
296 |
Mesenchymal stromal cells |
Human Umbilical Cord Mesenchymal Stem Cells |
- |
- |
- |
002 9件: 2 , 36, 49, 51, 60, 96, 97, 274, 284 💬 |
297 |
Metformin |
Metformin |
2件: D00944 D00944, D04966 D04966 💬 |
PRKAA1 2件: PRKAA1, PRKAA2 💬 |
AMPK signaling pathway 19件: AMPK signaling pathway, Adipocytokine signaling pathway, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway |
002 21件: 2 , 6 , 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬 |
298 |
Methylcobalamin |
Mecobalamin |
1件: D03246 D03246 💬 |
- |
- |
002 1件: 2 💬 |
299 |
Methylprednisolone |
Methylprednisolone |
6件: D00407 D00407, D00751 D00751, D00979 D00979, D05000 D05000, D05001 D05001, D05002 D05002 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
002 44件: 2 , 6 , 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 63, 64, 65, 66, 83, 84, 86, 96, 97, 127, 145, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296 💬 |
300 |
Mexiletine |
Mexiletine |
2件: D00639 D00639, D08215 D08215 💬 |
SCN1A 5件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes 3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction |
001 5件: 1 , 2 , 10, 113, 114 💬 |
301 |
Midazolam |
Midazolam |
3件: D00550 D00550, D00696 D00696, D05028 D05028 💬 |
GABRA1 16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 |
GABAergic synapse 7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction |
002 11件: 2 , 3 , 6 , 13, 21, 46, 70, 96, 97, 231, 298 💬 |
302 |
Minocycline |
Minocycline |
2件: D00850 D00850, D05045 D05045 💬 |
- |
- |
002 13件: 2 , 6 , 8 , 13, 46, 85, 90, 94, 162, 201, 206, 280, 299 💬 |
303 |
Mn-166 |
- |
- |
- |
- |
002 1件: 2 💬 |
304 |
Mnc (mononuclear cells) |
- |
- |
- |
- |
002 1件: 2 💬 |
305 |
Modal |
- |
- |
- |
- |
002 5件: 2 , 6 , 17, 46, 70 💬 |
306 |
Monitor |
Methamidophos |
- |
- |
- |
002 18件: 2 , 11, 13, 19, 46, 49, 58, 65, 70, 85, 86, 98, 113, 118, 129, 298, 299, 300 💬 |
307 |
Monthly autologous treg cells infusions + 3 times per week interleukin-2 injections |
Human interleukin-2 |
- |
- |
- |
002 1件: 2 💬 |
308 |
Moxifloxacin |
Moxifloxacin |
2件: D00874 D00874, D08237 D08237 💬 |
- |
- |
002 8件: 2 , 6 , 46, 49, 85, 86, 240, 299 💬 |
309 |
Msc-ntf cells transplantation (im) |
- |
- |
- |
- |
002 1件: 2 💬 |
310 |
Msc-ntf cells transplantation (it) |
- |
- |
- |
- |
002 1件: 2 💬 |
311 |
Msc_ntf cells transplantation by multiple intramuscular injections at 24 separate sites, in addition to a single intrathechal injection into the csf |
- |
- |
- |
- |
002 1件: 2 💬 |
312 |
Mt-1186 |
- |
- |
- |
- |
002 1件: 2 💬 |
313 |
Multiple dose |
- |
- |
- |
- |
002 1件: 2 💬 |
314 |
Mycophenolate |
Mycophenolic acid |
1件: D05096 D05096 💬 |
IMPDH1 2件: IMPDH1, IMPDH2 💬 |
Drug metabolism - other enzymes 3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism |
002 34件: 2 , 11, 13, 19, 20, 28, 35, 36, 42, 43, 45, 49, 51, 53, 60, 62, 65, 66, 84, 85, 93, 95, 96, 162, 164, 222, 224, 226, 228, 234, 283, 284, 285, 300 💬 |
315 |
Mycophenolate mofetil |
Mycophenolate mofetil |
4件: D00752 D00752, D05094 D05094, D05095 D05095, D05096 D05096 💬 |
IMPDH1 2件: IMPDH1, IMPDH2 💬 |
Drug metabolism - other enzymes 3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism |
002 32件: 2 , 11, 13, 19, 20, 28, 35, 36, 42, 43, 45, 49, 51, 53, 60, 62, 65, 66, 85, 93, 95, 96, 162, 164, 222, 224, 226, 234, 283, 284, 285, 300 💬 |
316 |
Myelostim 34*1fl 263mcg+1sir |
- |
- |
- |
- |
002 1件: 2 💬 |
317 |
Myonal |
- |
- |
- |
- |
002 1件: 2 💬 |
318 |
Myonal*30cpr riv 100mg |
- |
- |
- |
- |
002 1件: 2 💬 |
319 |
Nicotinamide |
Nicotinamide |
1件: D00036 D00036 💬 |
- |
- |
002 6件: 2 , 6 , 18, 49, 162, 191 💬 |
320 |
Nicotinamide riboside |
Nicotinamide |
1件: D00036 D00036 💬 |
- |
- |
002 4件: 2 , 6 , 18, 191 💬 |
321 |
Np001 |
- |
- |
- |
- |
002 1件: 2 💬 |
322 |
Ns |
- |
- |
- |
- |
002 1件: 2 💬 |
323 |
Nuedexta |
- |
- |
- |
- |
002 1件: 2 💬 |
324 |
Nurown® (msc-ntf cells) |
- |
- |
- |
- |
002 1件: 2 💬 |
325 |
Odm-109 |
- |
- |
- |
- |
002 1件: 2 💬 |
326 |
Odm-109 capsule 1 mg |
- |
- |
- |
- |
002 1件: 2 💬 |
327 |
Olanzapine |
Olanzapine |
2件: D00454 D00454, D06623 D06623 💬 |
ADRA1A 11件: ADRA1A, ADRA1B, ADRA1D, DRD2, DRD3, DRD4, HRH1, HTR2A, HTR2B, HTR2C, HTR6 💬 |
AMPK signaling pathway 16件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Alcoholism, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Salivary secretion, Serotonergic synapse, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
002 2件: 2 , 8 💬 |
328 |
Olesoxime |
- |
- |
- |
- |
002 2件: 2 , 3 💬 |
329 |
Ono-2506 |
- |
- |
- |
- |
002 1件: 2 💬 |
330 |
Ono-2506po |
- |
- |
- |
- |
002 2件: 2 , 6 💬 |
331 |
Oral levosimendan |
Levosimendan |
1件: D04720 D04720 💬 |
PDE3A 2件: PDE3A, PDE3B 💬 |
Apelin signaling pathway 11件: Apelin signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Progesterone-mediated oocyte maturation, Purine metabolism, Regulation of lipolysis in adipocytes, Renin secretion, cAMP signaling pathway, cGMP-PKG signaling pathway |
002 1件: 2 💬 |
332 |
Oral nutritional supplementation |
- |
- |
- |
- |
002 1件: 2 💬 |
333 |
Other: |
- |
- |
- |
- |
002 2件: 2 , 65 💬 |
334 |
Other: amyotrophic lateral sclerosis functional rating scale-revised |
- |
- |
- |
- |
002 1件: 2 💬 |
335 |
Other: communicative effectiveness survey |
- |
- |
- |
- |
002 1件: 2 💬 |
336 |
Other: control group |
- |
- |
- |
- |
002 1件: 2 💬 |
337 |
Other: eating assessment tool 10 |
- |
- |
- |
- |
002 1件: 2 💬 |
338 |
Other: eating assessment tool-10 |
- |
- |
- |
- |
002 1件: 2 💬 |
339 |
Other: functional oral intake scale |
- |
- |
- |
- |
002 1件: 2 💬 |
340 |
Other: historical control |
- |
- |
- |
- |
002 1件: 2 💬 |
341 |
Other: other: symptomatic treatment of als |
- |
- |
- |
- |
002 1件: 2 💬 |
342 |
Other: saline |
- |
- |
- |
- |
002 8件: 2 , 6 , 46, 97, 98, 256, 274, 301 💬 |
343 |
Other: swallowing quality of life questionnaire |
- |
- |
- |
- |
002 1件: 2 💬 |
344 |
Other: swallowing related quality of life questionnaire |
- |
- |
- |
- |
002 1件: 2 💬 |
345 |
Other: the center for neurologic studies bulbar function scale |
- |
- |
- |
- |
002 1件: 2 💬 |
346 |
Other: the center for neurologic study bulbar function scale |
- |
- |
- |
- |
002 1件: 2 💬 |
347 |
Oxepa |
- |
- |
- |
- |
002 1件: 2 💬 |
348 |
Ozanezumab |
Ozanezumab |
1件: D10331 D10331 💬 |
RTN4 1件: RTN4 💬 |
Alzheimer disease 1件: Alzheimer disease |
002 1件: 2 💬 |
349 |
Palmitoylethanolamide |
Palmidrol |
1件: D08328 D08328 💬 |
- |
- |
002 1件: 2 💬 |
350 |
Paracetamolo |
- |
- |
- |
- |
002 4件: 2 , 11, 14, 53 💬 |
351 |
Pbmc autotransplantation |
- |
- |
- |
- |
002 1件: 2 💬 |
352 |
Pegcetacoplan (apl-2) |
- |
- |
- |
- |
002 2件: 2 , 62 💬 |
353 |
Perampanel |
Perampanel |
1件: D08964 D08964 💬 |
GRIA1 4件: GRIA1, GRIA2, GRIA3, GRIA4 💬 |
Amphetamine addiction 16件: Amphetamine addiction, Amyotrophic lateral sclerosis, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Transcriptional misregulation in cancer, cAMP signaling pathway |
002 3件: 2 , 6 , 144 💬 |
354 |
Perfalgan |
- |
- |
- |
- |
002 1件: 2 💬 |
355 |
Phenylbutyrate |
Phenylbutyric acid |
1件: D05868 D05868 💬 |
- |
- |
002 11件: 2 , 3 , 6 , 8 , 15, 93, 94, 244, 251, 297, 299 💬 |
356 |
Phosphate |
Phosphate ion |
- |
- |
- |
002 30件: 2 , 3 , 11, 12, 13, 28, 36, 46, 49, 51, 53, 60, 62, 65, 70, 78, 81, 83, 90, 96, 97, 164, 235, 256, 276, 283, 284, 285, 286, 299 💬 |
357 |
Pimozide |
Pimozide |
1件: D00560 D00560 💬 |
DRD2 2件: DRD2, DRD3 💬 |
Alcoholism 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
002 1件: 2 💬 |
358 |
Pimozide 2 mg per day |
Pimozide |
1件: D00560 D00560 💬 |
DRD2 2件: DRD2, DRD3 💬 |
Alcoholism 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
002 1件: 2 💬 |
359 |
Pimozide 2mg/day (current) or 4 mg/day (study initiation) |
Pimozide |
1件: D00560 D00560 💬 |
DRD2 2件: DRD2, DRD3 💬 |
Alcoholism 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
002 1件: 2 💬 |
360 |
Pimozide 4 mg per day |
Pimozide |
1件: D00560 D00560 💬 |
DRD2 2件: DRD2, DRD3 💬 |
Alcoholism 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
002 1件: 2 💬 |
361 |
Pioglitazone |
Pioglitazone |
2件: D00945 D00945, D08378 D08378 💬 |
PPARG 1件: PPARG 💬 |
AMPK signaling pathway 9件: AMPK signaling pathway, Huntington disease, Longevity regulating pathway, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer |
002 17件: 2 , 6 , 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 💬 |
362 |
Pioglitazone and tretinoin |
Pioglitazone |
3件: D00094 D00094, D00945 D00945, D08378 D08378 💬 |
PML 4件: PML, PPARG, RARA, RARB 💬 |
AMPK signaling pathway 19件: AMPK signaling pathway, Acute myeloid leukemia, Endocytosis, Estrogen signaling pathway, Gastric cancer, Herpes simplex virus 1 infection, Huntington disease, Influenza A, Longevity regulating pathway, Non-small cell lung cancer, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer, Ubiquitin mediated proteolysis |
002 1件: 2 💬 |
363 |
Plasma from healthy young people treatment + riluzole |
Riluzole |
1件: D00775 D00775 💬 |
GRIA1 14件: GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 |
Alcoholism 23件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Systemic lupus erythematosus, Transcriptional misregulation in cancer, cAMP signaling pathway |
002 1件: 2 💬 |
364 |
Pleconaril |
Pleconaril |
1件: D05528 D05528 💬 |
- |
- |
002 1件: 2 💬 |
365 |
Plenur |
- |
- |
- |
- |
002 1件: 2 💬 |
366 |
Polymva |
- |
- |
- |
- |
002 1件: 2 💬 |
367 |
Pramipexole |
Pramipexole |
2件: D00559 D00559, D05575 D05575 💬 |
DRD2 3件: DRD2, DRD3, DRD4 💬 |
Alcoholism 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
002 2件: 2 , 6 💬 |
368 |
Prednisone |
Prednisone |
1件: D00473 D00473 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
002 47件: 2 , 6 , 11, 13, 14, 19, 26, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 61, 63, 64, 65, 66, 81, 84, 85, 86, 93, 95, 96, 97, 113, 127, 162, 164, 222, 224, 228, 251, 283, 284, 285, 288, 299, 300, 331 💬 |
369 |
Pridopidine |
Pridopidine |
1件: D09953 D09953 💬 |
DRD2 1件: DRD2 💬 |
Alcoholism 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
002 3件: 2 , 6 , 8 💬 |
370 |
Probiotic |
- |
- |
- |
- |
002 7件: 2 , 6 , 93, 96, 97, 193, 266 💬 |
371 |
Procedure: injection of salivary glands |
- |
- |
- |
- |
002 1件: 2 💬 |
372 |
Procedure: pulmonary function testing |
- |
- |
- |
- |
002 3件: 2 , 228, 299 💬 |
373 |
Procedure: umbilical cord blood therapy |
Umbilical Cord Blood Hematopoietic Stem Cells |
- |
- |
- |
002 2件: 2 , 6 💬 |
374 |
Procedure: videofluoroscopic swallowing study |
- |
- |
- |
- |
002 1件: 2 💬 |
375 |
Procedure: videofluoroscopic swallowing study (vfss) |
- |
- |
- |
- |
002 1件: 2 💬 |
376 |
Proleukin |
- |
- |
- |
- |
002 3件: 2 , 49, 65 💬 |
377 |
Proleukin 18 mui |
- |
- |
- |
- |
002 1件: 2 💬 |
378 |
Prototype capsule gdc-0134 |
- |
- |
- |
- |
002 1件: 2 💬 |
379 |
Pu-ad |
- |
- |
- |
- |
002 1件: 2 💬 |
380 |
Pyrimethamine |
Pyrimethamine |
1件: D00488 D00488 💬 |
- |
- |
002 4件: 2 , 4 , 19, 65 💬 |
381 |
Q-cells |
- |
- |
- |
- |
002 1件: 2 💬 |
382 |
Quinidine |
Quinidine |
4件: D00642 D00642, D00643 D00643, D02272 D02272, D08458 D08458 💬 |
SCN1A 5件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes 3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction |
002 3件: 2 , 8 , 13 💬 |
383 |
R(+) pramipexole dihydrochloride monohydrate |
Pramipexole |
2件: D00559 D00559, D05575 D05575 💬 |
DRD2 3件: DRD2, DRD3, DRD4 💬 |
Alcoholism 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
002 1件: 2 💬 |
384 |
Rabeprazole |
Rabeprazole |
2件: D00724 D00724, D08463 D08463 💬 |
ATP4A 2件: ATP4A, ATP4B 💬 |
Collecting duct acid secretion 4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation |
002 2件: 2 , 51 💬 |
385 |
Ranolazine |
Ranolazine |
2件: D05700 D05700, D05701 D05701 💬 |
- |
- |
002 6件: 2 , 58, 86, 96, 113, 114 💬 |
386 |
Ranolazine 1000 mg |
Ranolazine |
2件: D05700 D05700, D05701 D05701 💬 |
- |
- |
002 1件: 2 💬 |
387 |
Ranolazine 500 mg |
Ranolazine |
2件: D05700 D05700, D05701 D05701 💬 |
- |
- |
002 1件: 2 💬 |
388 |
Rapa-501 autologous t cells |
- |
- |
- |
- |
002 1件: 2 💬 |
389 |
Rapamune |
- |
- |
- |
- |
002 8件: 2 , 60, 66, 67, 84, 158, 278, 280 💬 |
390 |
Rapamune - 1 mg 100 compresse rivestite in blister uso orale |
- |
- |
- |
- |
002 1件: 2 💬 |
391 |
Rapamycin |
Sirolimus |
1件: D00753 D00753 💬 |
MTOR 1件: MTOR 💬 |
AMPK signaling pathway 50件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway |
002 18件: 2 , 15, 34, 35, 46, 49, 51, 60, 61, 67, 86, 89, 96, 157, 158, 256, 278, 279 💬 |
392 |
Rasagiline |
Rasagiline |
3件: D02562 D02562, D08469 D08469, D10829 D10829 💬 |
MAOB 1件: MAOB 💬 |
Alcoholism 14件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism |
002 4件: 2 , 5 , 6 , 17 💬 |
393 |
Rasagiline mesilate |
Rasagiline |
3件: D02562 D02562, D08469 D08469, D10829 D10829 💬 |
MAOB 1件: MAOB 💬 |
Alcoholism 14件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism |
002 3件: 2 , 5 , 6 💬 |
394 |
Ravulizumab |
Ravulizumab |
1件: D11054 D11054 💬 |
C5 1件: C5 💬 |
Complement and coagulation cascades 9件: Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Staphylococcus aureus infection, Systemic lupus erythematosus |
002 5件: 2 , 11, 13, 62, 109 💬 |
395 |
Recombinant human erythropoietin(rhepo) |
Erythropoietin |
1件: D03231 D03231 💬 |
EPOR 1件: EPOR 💬 |
Cytokine-cytokine receptor interaction 5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer |
002 1件: 2 💬 |
396 |
Reference capsule gdc-0134 |
- |
- |
- |
- |
002 1件: 2 💬 |
397 |
Reldesemtiv |
Reldesemtiv |
1件: D11363 D11363 💬 |
TNNC2 1件: TNNC2 💬 |
Calcium signaling pathway 1件: Calcium signaling pathway |
002 2件: 2 , 3 💬 |
398 |
Repository corticotropin injection |
Corticotropin |
1件: D00146 D00146 💬 |
MC2R 1件: MC2R 💬 |
Aldosterone synthesis and secretion 5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
002 5件: 2 , 13, 46, 84, 222 💬 |
399 |
Requip cr |
- |
- |
- |
- |
002 2件: 2 , 6 💬 |
400 |
Requip cr tablets |
- |
- |
- |
- |
002 1件: 2 💬 |
401 |
Resveratrol |
Resveratrol |
- |
- |
- |
002 6件: 2 , 8 , 18, 89, 113, 299 💬 |
402 |
Retigabine |
Ezogabine |
1件: D09569 D09569 💬 |
KCNQ1 5件: KCNQ1, KCNQ2, KCNQ3, KCNQ4, KCNQ5 💬 |
Adrenergic signaling in cardiomyocytes 6件: Adrenergic signaling in cardiomyocytes, Cholinergic synapse, Gastric acid secretion, Pancreatic secretion, Protein digestion and absorption, Vibrio cholerae infection |
002 2件: 2 , 144 💬 |
403 |
Ribavirin |
Ribavirin |
1件: D00423 D00423 💬 |
- |
- |
002 2件: 2 , 96 💬 |
404 |
Rilutek |
- |
- |
- |
- |
002 2件: 2 , 13 💬 |
405 |
Rilutek 50 mg film-coated tablets |
- |
- |
- |
- |
002 1件: 2 💬 |
406 |
Rilutek 50 mg, film-coated tablets |
- |
- |
- |
- |
002 1件: 2 💬 |
407 |
Riluzole |
Riluzole |
1件: D00775 D00775 💬 |
GRIA1 14件: GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 |
Alcoholism 23件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Systemic lupus erythematosus, Transcriptional misregulation in cancer, cAMP signaling pathway |
002 8件: 2 , 3 , 5 , 8 , 13, 17, 18, 206 💬 |
408 |
Riluzole (100 mg) |
Riluzole |
1件: D00775 D00775 💬 |
GRIA1 14件: GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 |
Alcoholism 23件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Systemic lupus erythematosus, Transcriptional misregulation in cancer, cAMP signaling pathway |
002 1件: 2 💬 |
409 |
Riluzole 50 mg |
Riluzole |
1件: D00775 D00775 💬 |
GRIA1 14件: GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 |
Alcoholism 23件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Systemic lupus erythematosus, Transcriptional misregulation in cancer, cAMP signaling pathway |
002 1件: 2 💬 |
410 |
Riluzole 50 mg (part b) |
Riluzole |
1件: D00775 D00775 💬 |
GRIA1 14件: GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 |
Alcoholism 23件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Systemic lupus erythematosus, Transcriptional misregulation in cancer, cAMP signaling pathway |
002 1件: 2 💬 |
411 |
Riluzole oral soluble film |
Riluzole |
1件: D00775 D00775 💬 |
GRIA1 14件: GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 |
Alcoholism 23件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Systemic lupus erythematosus, Transcriptional misregulation in cancer, cAMP signaling pathway |
002 1件: 2 💬 |
412 |
Riluzole oral soluble film (rosf) 50 mg |
Riluzole |
1件: D00775 D00775 💬 |
GRIA1 14件: GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 |
Alcoholism 23件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Systemic lupus erythematosus, Transcriptional misregulation in cancer, cAMP signaling pathway |
002 1件: 2 💬 |
413 |
Riluzolo |
- |
- |
- |
- |
002 2件: 2 , 114 💬 |
414 |
Ritonavir |
Ritonavir |
1件: D00427 D00427 💬 |
- |
- |
002 3件: 2 , 86, 265 💬 |
415 |
Rns60 |
- |
- |
- |
- |
002 2件: 2 , 13 💬 |
416 |
Saline solution |
- |
- |
- |
- |
002 4件: 2 , 34, 288, 299 💬 |
417 |
Sativex |
- |
- |
- |
- |
002 2件: 2 , 13 💬 |
418 |
Sb-509 |
- |
- |
- |
- |
002 1件: 2 💬 |
419 |
Scopolamine |
Scopolamine |
1件: D00138 D00138 💬 |
CHRM1 5件: CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬 |
Alzheimer disease 13件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway |
002 1件: 2 💬 |
420 |
Scopolamine, atropine, edaravone and dexmedetomidine |
Atropine |
9件: D00113 D00113, D00138 D00138, D00514 D00514, D01077 D01077, D01205 D01205, D01552 D01552, D02069 D02069, D03011 D03011, D03814 D03814 💬 |
ADRA2A 8件: ADRA2A, ADRA2B, ADRA2C, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬 |
Alzheimer disease 14件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway, cGMP-PKG signaling pathway |
002 1件: 2 💬 |
421 |
Selective serotonin uptake inhibitors (ssri) |
Serotonin |
- |
- |
- |
002 1件: 2 💬 |
422 |
Serine |
Serine |
1件: D00016 D00016 💬 |
- |
- |
002 3件: 2 , 6 , 86 💬 |
423 |
Serotonin |
Serotonin |
- |
- |
- |
002 1件: 2 💬 |
424 |
Single dose reduced |
- |
- |
- |
- |
002 1件: 2 💬 |
425 |
Single dose standard |
- |
- |
- |
- |
002 1件: 2 💬 |
426 |
Snn0029 |
- |
- |
- |
- |
002 1件: 2 💬 |
427 |
Snn0029 infusion solution |
- |
- |
- |
- |
002 1件: 2 💬 |
428 |
Sodium phenylbutyrate |
Phenylbutyric acid |
1件: D05868 D05868 💬 |
- |
- |
002 4件: 2 , 3 , 8 , 251 💬 |
429 |
Sodium pyruvate |
- |
- |
- |
- |
002 1件: 2 💬 |
430 |
Sodium valproate |
Valproic acid |
1件: D00399 D00399 💬 |
ABAT 7件: ABAT, ALDH5A1, CACNA1G, CACNA1H, CACNA1I, GAD1, GAD2 💬 |
Alanine, aspartate and glutamate metabolism 17件: Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, GnRH secretion, MAPK signaling pathway, Metabolic pathways, Propanoate metabolism, Taurine and hypotaurine metabolism, Type I diabetes mellitus, Type II diabetes mellitus, Valine, leucine and isoleucine degradation, beta-Alanine metabolism |
002 4件: 2 , 90, 102, 256 💬 |
431 |
Somatropin |
Somatotropin |
1件: D02691 D02691 💬 |
GHR 1件: GHR 💬 |
Cytokine-cytokine receptor interaction 5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
002 16件: 2 , 3 , 19, 46, 74, 75, 78, 96, 113, 187, 193, 195, 265, 274, 276, 299 💬 |
432 |
Spect : 123 i-fp-cit (datscan) and 123i-adam |
- |
- |
- |
- |
002 1件: 2 💬 |
433 |
Spirit1 |
- |
- |
- |
- |
002 1件: 2 💬 |
434 |
Stem cell |
- |
- |
- |
- |
002 2件: 2 , 113 💬 |
435 |
Stem cell (hpc) implantation |
- |
- |
- |
- |
002 1件: 2 💬 |
436 |
Stem cells |
- |
- |
- |
- |
002 4件: 2 , 4 , 96, 113 💬 |
437 |
Sub126308 |
- |
- |
- |
- |
002 1件: 2 💬 |
438 |
Sulfate |
Sulfate ion |
- |
- |
- |
002 25件: 2 , 6 , 11, 13, 26, 28, 34, 36, 46, 49, 53, 60, 64, 66, 79, 85, 86, 96, 111, 222, 226, 265, 296, 297, 299 💬 |
439 |
Suspension of human autologous msc 3p in 1,5 ml |
- |
- |
- |
- |
002 1件: 2 💬 |
440 |
Suspension of human autologous msc 3p in 1.5 ml |
- |
- |
- |
- |
002 1件: 2 💬 |
441 |
Tacrolimus |
Tacrolimus |
2件: D00107 D00107, D08556 D08556 💬 |
PPP3CA 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease 32件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
002 32件: 2 , 6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬 |
442 |
Talampanel |
Talampanel |
1件: D02696 D02696 💬 |
GRIA1 4件: GRIA1, GRIA2, GRIA3, GRIA4 💬 |
Amphetamine addiction 16件: Amphetamine addiction, Amyotrophic lateral sclerosis, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Transcriptional misregulation in cancer, cAMP signaling pathway |
002 2件: 2 , 6 💬 |
443 |
Tallampanel |
- |
- |
- |
- |
002 1件: 2 💬 |
444 |
Tamoxifen |
Tamoxifen |
2件: D00966 D00966, D08559 D08559 💬 |
ESR1 2件: ESR1, ESR2 💬 |
Breast cancer 9件: Breast cancer, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway |
002 4件: 2 , 86, 113, 227 💬 |
445 |
Tamoxifen 40 mg daily for one year |
Tamoxifen |
2件: D00966 D00966, D08559 D08559 💬 |
ESR1 2件: ESR1, ESR2 💬 |
Breast cancer 9件: Breast cancer, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway |
002 1件: 2 💬 |
446 |
Taurolite |
- |
- |
- |
- |
002 1件: 2 💬 |
447 |
Tauroursodeoxycholic acid |
Tauroursodeoxycholic acid |
1件: D11836 D11836 💬 |
- |
- |
002 4件: 2 , 13, 93, 299 💬 |
448 |
Tauroursodeoxycholic acid (tudca) |
Tauroursodeoxycholic acid |
1件: D11836 D11836 💬 |
- |
- |
002 1件: 2 💬 |
449 |
Tch346 |
- |
- |
- |
- |
002 1件: 2 💬 |
450 |
Tenofovir |
Tenofovir |
1件: D06074 D06074 💬 |
- |
- |
002 5件: 2 , 25, 93, 265, 325 💬 |
451 |
Tenofovir alafenamide |
Tenofovir |
2件: D06074 D06074, D10428 D10428 💬 |
- |
- |
002 1件: 2 💬 |
452 |
Tenofovir alafenamide (taf) |
Tenofovir |
2件: D06074 D06074, D10428 D10428 💬 |
- |
- |
002 1件: 2 💬 |
453 |
Testosterone |
Testosterone |
6件: D00075 D00075, D00957 D00957, D00958 D00958, D00959 D00959, D06085 D06085, D06087 D06087 💬 |
AR 1件: AR 💬 |
Oocyte meiosis 3件: Oocyte meiosis, Pathways in cancer, Prostate cancer |
001 8件: 1 , 2 , 3 , 13, 60, 78, 113, 265 💬 |
454 |
Tevagrastim |
- |
- |
- |
- |
002 1件: 2 💬 |
455 |
Thalidomide |
Thalidomide |
1件: D00754 D00754 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
002 20件: 2 , 16, 20, 28, 49, 51, 53, 56, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 300, 331 💬 |
456 |
Thalidomide (drug) |
Thalidomide |
1件: D00754 D00754 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
002 1件: 2 💬 |
457 |
Theracurmin hp |
- |
- |
- |
- |
002 1件: 2 💬 |
458 |
Tioctic acid |
- |
- |
- |
- |
002 1件: 2 💬 |
459 |
Tirasemtiv |
Tirasemtiv |
1件: D10327 D10327 💬 |
- |
- |
002 1件: 2 💬 |
460 |
Tocilizumab |
Tocilizumab |
1件: D02596 D02596 💬 |
IL6R 1件: IL6R 💬 |
Coronavirus disease - COVID-19 12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor |
002 18件: 2 , 13, 40, 41, 42, 43, 46, 50, 51, 53, 54, 55, 56, 86, 107, 266, 271, 331 💬 |
461 |
Tocotrienols |
- |
- |
- |
- |
002 1件: 2 💬 |
462 |
Trametinib |
Trametinib |
1件: D10175 D10175 💬 |
MAP2K1 2件: MAP2K1, MAP2K2 💬 |
Acute myeloid leukemia 87件: Acute myeloid leukemia, Alcoholism, Alzheimer disease, Apelin signaling pathway, Apoptosis, Autophagy - animal, B cell receptor signaling pathway, Bladder cancer, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Cushing syndrome, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endometrial cancer, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, Insulin signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Long-term depression, Long-term potentiation, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-small cell lung cancer, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Serotonergic synapse, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Thyroid cancer, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, VEGF signaling pathway, Vascular smooth muscle contraction, Yersinia infection, cAMP signaling pathway, cGMP-PKG signaling pathway, mTOR signaling pathway |
002 3件: 2 , 34, 279 💬 |
463 |
Trametinib (0.5 mg) |
Trametinib |
1件: D10175 D10175 💬 |
MAP2K1 2件: MAP2K1, MAP2K2 💬 |
Acute myeloid leukemia 87件: Acute myeloid leukemia, Alcoholism, Alzheimer disease, Apelin signaling pathway, Apoptosis, Autophagy - animal, B cell receptor signaling pathway, Bladder cancer, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Cushing syndrome, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endometrial cancer, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, Insulin signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Long-term depression, Long-term potentiation, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-small cell lung cancer, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Serotonergic synapse, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Thyroid cancer, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, VEGF signaling pathway, Vascular smooth muscle contraction, Yersinia infection, cAMP signaling pathway, cGMP-PKG signaling pathway, mTOR signaling pathway |
002 1件: 2 💬 |
464 |
Trametinib (1 mg) |
Trametinib |
1件: D10175 D10175 💬 |
MAP2K1 2件: MAP2K1, MAP2K2 💬 |
Acute myeloid leukemia 87件: Acute myeloid leukemia, Alcoholism, Alzheimer disease, Apelin signaling pathway, Apoptosis, Autophagy - animal, B cell receptor signaling pathway, Bladder cancer, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Cushing syndrome, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endometrial cancer, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, Insulin signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Long-term depression, Long-term potentiation, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-small cell lung cancer, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Serotonergic synapse, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Thyroid cancer, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, VEGF signaling pathway, Vascular smooth muscle contraction, Yersinia infection, cAMP signaling pathway, cGMP-PKG signaling pathway, mTOR signaling pathway |
002 1件: 2 💬 |
465 |
Trametinib (2 mg) |
Trametinib |
1件: D10175 D10175 💬 |
MAP2K1 2件: MAP2K1, MAP2K2 💬 |
Acute myeloid leukemia 87件: Acute myeloid leukemia, Alcoholism, Alzheimer disease, Apelin signaling pathway, Apoptosis, Autophagy - animal, B cell receptor signaling pathway, Bladder cancer, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Cushing syndrome, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endometrial cancer, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, Insulin signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Long-term depression, Long-term potentiation, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-small cell lung cancer, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Serotonergic synapse, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Thyroid cancer, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, VEGF signaling pathway, Vascular smooth muscle contraction, Yersinia infection, cAMP signaling pathway, cGMP-PKG signaling pathway, mTOR signaling pathway |
002 1件: 2 💬 |
466 |
Trazodone |
Trazodone |
2件: D00820 D00820, D08626 D08626 💬 |
HTR2A 4件: HTR2A, HTR2B, HTR2C, SLC6A4 💬 |
Calcium signaling pathway 6件: Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle |
002 1件: 2 💬 |
467 |
Trazodone hydrochloride oral solution |
Trazodone |
2件: D00820 D00820, D08626 D08626 💬 |
HTR2A 4件: HTR2A, HTR2B, HTR2C, SLC6A4 💬 |
Calcium signaling pathway 6件: Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle |
002 1件: 2 💬 |
468 |
Tretinoin |
Tretinoin |
1件: D00094 D00094 💬 |
PML 3件: PML, RARA, RARB 💬 |
Acute myeloid leukemia 12件: Acute myeloid leukemia, Endocytosis, Estrogen signaling pathway, Gastric cancer, Herpes simplex virus 1 infection, Influenza A, Non-small cell lung cancer, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Transcriptional misregulation in cancer, Ubiquitin mediated proteolysis |
002 2件: 2 , 75 💬 |
469 |
Tretinoin and pioglitazone hcl |
Pioglitazone |
3件: D00094 D00094, D00945 D00945, D08378 D08378 💬 |
PML 4件: PML, PPARG, RARA, RARB 💬 |
AMPK signaling pathway 19件: AMPK signaling pathway, Acute myeloid leukemia, Endocytosis, Estrogen signaling pathway, Gastric cancer, Herpes simplex virus 1 infection, Huntington disease, Influenza A, Longevity regulating pathway, Non-small cell lung cancer, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer, Ubiquitin mediated proteolysis |
002 1件: 2 💬 |
470 |
Tricyclic antidepressants (tca) |
- |
- |
- |
- |
002 1件: 2 💬 |
471 |
Triheptanoin |
Triheptanoin |
1件: D11465 D11465 💬 |
- |
- |
002 9件: 2 , 8 , 149, 156, 248, 256, 257, 317, 324 💬 |
472 |
Triumeq |
- |
- |
- |
- |
002 1件: 2 💬 |
473 |
Tro19622 |
TRO19622 |
- |
- |
- |
002 3件: 2 , 3 , 13 💬 |
474 |
Trobalt |
- |
- |
- |
- |
002 1件: 2 💬 |
475 |
Tudca |
Tauroursodeoxycholic acid |
1件: D11836 D11836 💬 |
- |
- |
002 1件: 2 💬 |
476 |
Tudcabil |
- |
- |
- |
- |
002 1件: 2 💬 |
477 |
Tv-7110 |
- |
- |
- |
- |
002 1件: 2 💬 |
478 |
Téralithe lp |
- |
- |
- |
- |
002 1件: 2 💬 |
479 |
Ultomiris |
- |
- |
- |
- |
002 4件: 2 , 11, 13, 62 💬 |
480 |
Ultra-high-caloric carbohydrate-rich diet |
- |
- |
- |
- |
002 1件: 2 💬 |
481 |
Ultra-high-caloric fatty diet |
- |
- |
- |
- |
002 1件: 2 💬 |
482 |
Valproate |
Valproic acid |
1件: D00399 D00399 💬 |
ABAT 7件: ABAT, ALDH5A1, CACNA1G, CACNA1H, CACNA1I, GAD1, GAD2 💬 |
Alanine, aspartate and glutamate metabolism 17件: Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, GnRH secretion, MAPK signaling pathway, Metabolic pathways, Propanoate metabolism, Taurine and hypotaurine metabolism, Type I diabetes mellitus, Type II diabetes mellitus, Valine, leucine and isoleucine degradation, beta-Alanine metabolism |
002 6件: 2 , 3 , 90, 102, 233, 256 💬 |
483 |
Verdiperstat |
Verdiperstat |
1件: D11684 D11684 💬 |
MPO 1件: MPO 💬 |
Acute myeloid leukemia 5件: Acute myeloid leukemia, Drug metabolism - other enzymes, Neutrophil extracellular trap formation, Phagosome, Transcriptional misregulation in cancer |
002 2件: 2 , 17 💬 |
484 |
Vitamin e |
Vitamin E |
1件: D02331 D02331 💬 |
- |
- |
002 11件: 2 , 6 , 13, 20, 46, 90, 96, 97, 206, 299, 317 💬 |
485 |
Vm202 |
- |
- |
- |
- |
002 1件: 2 💬 |
486 |
Water |
Water |
1件: D00001 D00001 💬 |
- |
- |
002 22件: 2 , 5 , 6 , 13, 17, 19, 35, 46, 51, 53, 56, 57, 63, 65, 67, 78, 84, 96, 97, 226, 278, 299 💬 |
487 |
Yam80 |
- |
- |
- |
- |
002 1件: 2 💬 |
488 |
Zibren |
- |
- |
- |
- |
002 1件: 2 💬 |
489 |
Zibren*20bust 500mg |
- |
- |
- |
- |
002 1件: 2 💬 |
490 |
Zilucoplan |
Zilucoplan |
- |
- |
- |
002 3件: 2 , 11, 62 💬 |
491 |
Zinc |
Zinc |
- |
- |
- |
002 3件: 2 , 171, 299 💬 |
492 |
Zinc and copper |
Copper |
- |
- |
- |
002 1件: 2 💬 |
493 |
Zyprexa |
- |
- |
- |
- |
002 1件: 2 💬 |